Search results for:
tocilizumab
tocilizumab
| Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-formulary |
Interchange |
| Actemra |
SOLUTION |
80 mg/ 4ml; 200 mg / 10 ml vial & 400 mg/ 20 ml vial |
|
|
|
|
| Avtozma (-anoh) |
SOLUTION FOR INFUSION |
80 mg/ 4ml; 200 mg / 10 ml vial & 400 mg/ 20 ml vial |
|
|
|
|
Last updated: Mar. 24, 2026
Add Formweb to your mobile device
Preferred biosimilar agent for Inpatient or Outpatient use: Avtozma (-anoh)
Non-Preferred agents will only be procured for scheduled infusion patients with an approved PA whose insurance will not cover our preferred agent(s).